Home > > > Report Detail

Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027

Publisher Name :
Date: 02-Dec-2022
No. of pages: 253
Inquire Before Buying

“Increasing adoption of biopharmaceuticals and technological advancements in API manufacturing is expected to drive the overall growth of the global APIs market.”

The global Active Pharmaceutical Ingredient (APIs) market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the growing importance of generics, and the rising focus on precision medicine are some of the major factors driving the growth of the global APIs market.

“The biotech APIs segment is expected to grow at the highest CAGR during the forecast period.”

On the basis ofthe type of synthesis, the APIs market is categorized into synthetic APIs and biotech APIs. In 2021, the synthetic APIs segment accounted for the largest share. However, the biotech APIs segment is expected to grow at a higher rate over the forecast period. Factors such as the growing demand for biotech drugs due to their specificity in action and advancements in biotechnology are driving market growth in the market.

“The monoclonal antibodies segment is expected to account for the largest share of the global biotech APIs market.”

Based on product, the biotech APIs market is segmented into monoclonal antibodies, hormones& growth factors, cytokines, fusion proteins, therapeutic enzymes, recombinant vaccines, and blood factors. In 2021, the monoclonal antibodies segment was estimated to account for the largest share of the biotech APIs market.

“North America to dominate the market during the forecast period.”

In 2021, North America dominated the market, followed by Europe. The major factors driving the overall growth of the APIs market in this region include the presence of major pharmaceutical and biopharmaceutical manufacturing facilities, an increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures as well as the introduction of low-cost and generic versions of branded drugs.

Breakdown of the profile of primary participants:


  • By Company Type: Tier 1 – 37%, Tier 2 – 22%, and Tier 3 – 41%

  • By Designation: C-level Executives – 25%, Directors – 20%, Others - 55%

  • By Region: North America – 40%, Europe – 27%, Asia Pacific – 20%, and RoW – 13%


List of companies profiled in the report


  • Pfizer, Inc. (US),

  • Novartis AG (Switzerland),

  • Sanofi (France),

  • Boehringer Ingelheim (Germany),

  • Bristol-Myers Squibb (US),

  • Teva Pharmaceutical Industries Ltd. (Israel),

  • Eli Lilly and Company (US),

  • GlaxoSmithKline plc (UK),

  • Merck & Co., Inc. (US),

  • AbbVie Inc. (US),

  • F. Hoffmann-La Roche Ltd. (Switzerland),

  • AstraZeneca (UK),

  • Cipla, Inc. (India),

  • Mylan N.V. (US),

  • Dr. Reddy’s Laboratories Ltd. (India),

  • Sun Pharmaceutical Industries Ltd. (India),

  • API Pharma Tech (India),

  • BDR Pharmaceuticals Internationals Pvt. Ltd. (India),

  • Sreepathi Pharmaceuticals Limited (India),

  • Shilpa Medicare Limited (India),

  • Evonik Industries AG (Germany),

  • Aurobindo Pharma Limited (India).


Research Coverage:

This report provides a picture of the global APIs market. It aims at estimating the size and future growth potential of the market across different segments, such as type, potency, type of synthesis, type of drug, therapeutic application, and region. Furthermore, the report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall APIs market and its sub segments. Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027

Table Of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered
1.4 Currency Considered
1.5 Research Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown And Data Triangulation
2.4 Market Share Estimation
2.5 Study Assumptions

3 Executive Summary

4 Premium Insights
4.1 Active Pharmaceutical Ingredients: Market Overview
4.2 Active Pharmaceutical Ingredients Market, By Type
4.3 Active Pharmaceutical Ingredients Market, By Potency
4.4 Active Pharmaceutical Ingredients Market, By Type Of Synthesis
4.5 Active Pharmaceutical Ingredients Market, By Type Of Drug
4.6 Geographic Snapshot: Active Pharmaceutical Ingredients Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Importance Of Generics
5.2.1.2 Increasing Uptake Of Biopharmaceuticals
5.2.1.3 Growing Focus On Precision Medicine
5.2.1.4 Technological Advancements In Api Manufacturing
5.2.1.5 Increasing Incidence Of Chronic Diseases
5.2.2 Restraints
5.2.2.1 Unfavorable Drug Price Control Policies Across Various Countries
5.2.2.2 High Manufacturing Cost
5.2.3 Opportunities
5.2.3.1 Emerging Biosimilars Market
5.2.3.2 Highly Potent Active Pharmaceutical Ingredients
5.2.3.3 Emerging Markets
5.2.3.4 Emerging Technologies
5.2.4 Challenges
5.2.4.1 Increasing Penetration Of Counterfeit Drugs
5.3 Value Chain Analysis
5.4 Supply Chain Analysis
5.5 Ecosystem Analysis
5.6 Patent Analysis
5.7 Key Conferences And Events
5.8 Tariff And Regulatory Landscape
5.9 Porter’s Five Forces Analysis
5.10 Key Stakeholders In Buying Process
5.11 Indicative Pricing Analysis
5.12 Trade Analysis

6 Active Pharmaceutical Ingredients Market, By Type
6.1 Introduction
6.2 Active Pharmaceutical Ingredients Market, By Type (Captive And Merchant)
6.3 Innovative Active Pharmaceutical Ingredients
6.3.1 Growing Number Of New Molecular Entities To Have Regulatory Approvaldrive Market
6.4 Generic Active Pharmaceutical Ingredients
6.4.1 Government Initiatives Supporting Generic Drugs Adoption To Boostmarket

7 Active Pharmaceutical Ingredients Market, By Potency
7.1 Introduction
7.2 Active Pharmaceutical Ingredients Market, By Potency (Captive And Merchant)
7.3 Traditional Api
7.3.1 Properties Of Traditional Apis Like, Heightened Potency, Quick Absorptionrates, And Have A Suspected Or Known Genic Effect To Drive Market Growth
7.4 Hpapi
7.4.1 Hpapis Increasing Applications Across A Range Of Therapeutic Areas Aredriving The Market Growth

8 Active Pharmaceutical Ingredients Market, By Type Of Synthesis
8.1 Introduction
8.2 Active Pharmaceutical Ingredients Market, By Type Of Synthesis (Captive Andmerchant)
8.3 Synthetic Active Pharmaceutical Ingredients
8.3.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
8.3.1.1 Innovative Synthetic Apis
8.3.1.1.1 High Value Of Innovative Apis To Drive Segment
8.3.1.2 Generic Synthetic Apis
8.3.1.2.1 Initiatives For Penetration Of Generics To Bring Down Healthcare Costs
8.4 Biotech Active Pharmaceutical Ingredients
8.4.1 Biotech Active Pharmaceutical Ingredients Market, By Type
8.4.1.1 Innovative Biotech Apis
8.4.1.1.1 Growing Demand For Innovative Biopharmaceuticals To Drive Segment
8.4.1.2 Generic Biotech Apis
8.4.1.2.1 Increasing Demand For Biosimilar Drugs Due To Their Cost-Effectiveness To Drivesegment
8.5.2 Biotech Active Pharmaceutical Ingredients Market, By Product
8.5.2.1 Monoclonal Antibodies
8.5.2.1.1 Growing Applications Of Antibody-Drug Conjugates In Cancer Treatment To Drivesegment
8.5.2.2 Hormones & Growth Factors
8.5.2.2.1 Growing Incidence Of Hormonal Disorders To Boost Segment
8.5.2.3 Cytokines
8.5.2.3.1 Interferons And Interleukins Boost Immune System And Have Importantapplications In Cancer Treatment
8.5.2.4 Fusion Proteins
8.5.2.4.1 Growing Applications Of Fusion Proteins In Biopharmaceuticals To Drive Segment
8.5.2.5 Recombinant Vaccines
8.5.2.5.1 Growing Prevalence Of Infectious Diseases To Boost Vaccine Development
8.5.2.6 Therapeutic Enzymes
8.5.2.6.1 Growing Significance Of Enzymes In Therapies For Cancer And Pain Management Todrive Segment
8.5.2.7 Blood Factors
8.5.2.7.1 Growing Incidence Of Hemophilia To Drive The Growth Of This Segment
8.6.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
8.6.3.1 Mammalian Expression Systems
8.6.3.1.1 Ability Of These Systems To Carry Post-Translational Modification To Drive Segment
8.6.3.2 Microbial Expression Systems
8.6.3.2.1 Ability To Provide High Expression Levels Of Proteins To Drive Segment
8.6.3.3 Yeast Expression Systems
8.6.3.3.1 Advantages Such As Efficient Protein Secretion, Simple Purification, And Endotoxin-
Free Products To Boost Demand
8.6.3.4 Insect Expression Systems
8.6.3.4.1 Efficient Post-Translational Modifications Provided By These Systems To Boostdemand
8.6.3.5 Other Expression Systems

9 Active Pharmaceutical Ingredients Market, By Type Of Drug
9.1 Introduction
9.2 Active Pharmaceutical Ingredients Market, By Type Of Drug (Captive Andmerchant)
9.3 Prescription Drugs
9.3.1 Growing Disease Prevalence To Drive Market
9.4 Over-The-Counter Drugs
9.4.1 Sales Of Otc Drugs To Rise Due To Innovations, Promotion Of Self-Medication, And Increased Access

10 Active Pharmaceutical Ingredients Market, By Therapeutic Application
10.1 Introduction
10.2 Active Pharmaceutical Ingredients Market, By Therapeutic Application(Captive And Merchant)
10.3 Communicable Diseases
10.3.1 Global Health Impact Of Communicable Diseases And Increasingantimicrobial Resistance To Aid Market
10.4 Oncology
10.4.1 Increase In Global Spending On Cancer Medication To Augment Growth
10.5 Pain Management
10.5.1 Increasing Demand For Innovative And Advanced Pain Medications To Drivemarket
10.6 Cardiovascular Diseases
10.6.1 Growing Incidence Of Cardiovascular Diseases Owing To Sedentarylifestyles To Aid Market
10.7 Diabetes
10.7.1 High Global Prevalence Of Diabetes To Drive Segment
10.8 Respiratory Diseases
10.8.1 High Global Prevalence Of Respiratory Diseases To Propel Growth
10.9 Other Therapeutic Applications

11 Active Pharmaceutical Ingredients Market, By Region
11.1 Introduction
11.2 Active Pharmaceutical Ingredients Market, By Region (Captive And Merchant)
11.3 North America
11.3.1 Us
11.3.1.1 Increasing Expenditure On Medicine To Drive Market
11.3.2 Canada
11.3.2.1 Support From Government Organizations To Propel Growth
11.4 Europe
11.4.1 Germany
11.4.1.1 Germany To Dominate European Market In 2021
11.4.2 France
11.4.2.1 Emergence Of Pharmerging Markets In Asia To Hinder Growth
11.4.3 Uk
11.4.3.1 Growing Adoption Of Generics To Drive Market
11.4.4 Italy
11.4.4.1 Italy’s Share In Merchant Apis Market To Remain Stable During Forecast Period
11.4.5 Spain
11.4.5.1 Spanish Market To Be Dominated By Branded Drugs
11.4.6 Rest Of Europe
11.5 Asia Pacific
11.5.1 Japan
11.5.1.1 Japanese Government To Boost Use Of Generics By 2020
11.5.2 China
11.5.2.1 Government Policies To Increase Medicine Access And Affordability
11.5.3 India
11.5.3.1 India To Be Leading Producer Of Generics
11.5.4 South Korea
11.5.4.1 Government Initiatives To Introduce Full Medical Coverage For Major Chronic Diseases
11.5.5 Rest Of Asia
11.6 Rest Of The World

12 Competitive Landscape
12.1 Overview
12.2 Key Player Strategies/ Right To Win
12.3 Market Share Analysis
12.4 Revenue Share Analysis Of Top Market Players
12.5 Competitive Evaluation Quadrant
12.3.1 Stars
12.3.2 Emerging Leaders
12.3.3 Pervasive Players
12.3.4 Participants
12.4 Company Evaluation Quadrant
12.4.1 Progressive Companies
12.4.2 Starting Blocks
12.4.3 Responsive Companies
12.4.4 Dynamic Companies
12.4 Regional Footprint Of Companies
12.5 Competitive Scenario

13 Company Profiles
(Business Overview, Products Offered, Recent Developments, Mnm View)*
13.1 Pfizer, Inc.
13.2 Novartis Ag
13.3 Sanofi
13.4 Boehringer Ingelheim
13.5 Bristol-Myers Squibb
13.6 Teva Pharmaceutical Industries Ltd.
13.7 Eli Lilly And Company
13.8 Glaxosmithkline Plc
13.9 Merck & Co., Inc.
13.10 Abbvie Inc.
13.11 F. Hoffmann-La Roche
13.12 Astrazeneca
13.13 Mylan Nv
13.14 Dr Reddy’s Laboratories Ltd.
13.15 Sun Pharmaceutical Ltd.
13.16 Cipla Inc.
13.17 Aurobindo Pharma Ltd.
13.18 Evonik Industries Ag
13.19 Api Pharma Tech
13.20 Sreepathi Pharmaceuticals Ltd.
13.21 Bdr Pharmaceuticals International Ltd.
13.22 Shilpa Medicare Ltd.

14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
14.3 Customization Options
14.4 Related Reports
14.5 Author Details

List Of Tables

Table 1 Indicative List Of Drugs Going Generic In 2021
Table 2 Indicative List Of Biologics That Gained Regulatory Approval In Us In 2019-2021
Table 3 Indicative List Of Biosimilars That Gained Us Regulatory Approval In 2021
Table 4 Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 5 Indicative List Of New Molecular Entities That Gained Us Fda Approval In 2021
Table 6 List Of Major Drugs Set To Lose Patent Protection In 2021
Table 7 Innovative Active Pharmaceutical Ingredients Market, By Region, 2022–2027(Usd Billion)
Table 8 Generic Active Pharmaceutical Ingredients Market, By Region, 2022–2027 (Usdbillion)
Table 9 Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027(Usd Billion)
Table 10 Synthetic Active Pharmaceutical Ingredients Market, By Region, 2022–2027(Usd Billion)
Table 11 Synthetic Active Pharmaceutical Ingredients Market, By Type 2022–2027 (Usdbillion)
Table 12 Innovative Synthetic Active Pharmaceutical Ingredients Market, By Region,2022–2027 (Usd Billion)
Table 13 Generic Synthetic Active Pharmaceutical Ingredients Market, By Region,2022–2027 (Usd Billion)
Table 14 Top Selling Biologics (2021)
Table 15 Biotech Active Pharmaceutical Ingredients Market, By Region, 2022–2027 (Usdbillion)
Table 16 Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 17 Innovative Biotech Active Pharmaceutical Ingredients Market, By Region,2022–2027 (Usd Billion)
Table 18 Indicative List Of Biosimilars That Gained Us Fda Approval During 2017–2018
Table 19 Generic Biotech Active Pharmaceutical Ingredients Market, By Region, 2022–2027 (Usd Billion)
Table 20 Biotech Active Pharmaceutical Ingredients Market, By Product 2022–2027(Usd Billion)
Table 21 Indicative List Of Monoclonal Antibodies That Received Fda Approval In 2018
Table 22 Biotech Active Pharmaceutical Ingredients Market For Monoclonalantibodies, By Region, 2022–2027 (Usd Billion)
Table 23 Biotech Active Pharmaceutical Ingredients Market For Hormones & Growth Factors, By Region, 2022–2027 (Usd Billion)
Table 24 Biotech Active Pharmaceutical Ingredients Market For Cytokines, By Region,2022–2027 (Usd Billion)
Table 25 Biotech Active Pharmaceutical Ingredients Market For Fusion Proteins, Byregion, 2022–2027 (Usd Billion)
Table 26 Biotech Active Pharmaceutical Ingredients Market For Recombinantvaccines, By Region, 2022–2027 (Usd Million)
Table 27 Biotech Active Pharmaceutical Ingredients Market For Therapeuticenzymes, By Region, 2022–2027 (Usd Million)
Table 28 Biotech Active Pharmaceutical Ingredients Market For Blood Factors, Byregion, 2022–2027 (Usd Million)
Table 29 Biotech Active Pharmaceutical Ingredients Market, By Expression System,2022–2027 (Usd Billion)
Table 30 Biotech Active Pharmaceutical Ingredients Market For Mammalianexpression Systems, By Region, 2022–2027 (Usd Billion)
Table 31 Biotech Active Pharmaceutical Ingredients Market For Microbialexpression Systems, By Region, 2022–2027 (Usd Billion)
Table 32 Biotech Active Pharmaceutical Ingredients Market For Yeast Expressionsystems, By Region, 2022–2027 (Usd Billion)
Table 33 Biotech Active Pharmaceutical Ingredients Market For Insect Expressionsystems, By Region, 2022–2027 (Usd Billion)
Table 34 Biotech Active Pharmaceutical Ingredients Market For Other Expressionsystems, By Region, 2022–2027 (Usd Million)
Table 35 Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usdbillion)
Table 36 Prescription Drugs Market, By Region, 2022–2027 (Usd Billion)
Table 37 Over-The-Counter Drugs Market, By Region, 2017-2024 (Usd Billion)
Table 38 Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usd Billion)
Table 39 Active Pharmaceutical Ingredients Market, By Therapeutic Application, 2022–2027 (Usd Billion)
Table 40 Indicative List Of Us Fda-Approved Drugs For Communicable Diseases (2021)
Table 41 Active Pharmaceutical Ingredients Market For Communicable Diseases, Byregion, 2022–2027 (Usd Billion)
Table 42 Indicative List Of Us Fda-Approved Drugs For Oncology (2021)
Table 43 Active Pharmaceutical Ingredients Market For Oncology, By Region, 2022–2027 (Usd Billion)
Table 44 Indicative List Of Us Fda-Approved Drugs For Pain Management (2021)
Table 45 Active Pharmaceutical Ingredients Market For Pain Management, By Region,2022–2027 (Usd Billion)
Table 46 Active Pharmaceutical Ingredients Market For Cardiovascular Diseases, Byregion, 2022–2027 (Usd Billion)
Table 47 Active Pharmaceutical Ingredients Market For Diabetes, By Region, 2022–2027(Usd Billion)
Table 48 Active Pharmaceutical Ingredients Market For Respiratory Diseases, Byregion, 2022–2027 (Usd Billion)
Table 49 Active Pharmaceutical Ingredients Market For Other Therapeuticapplications, By Region, 2022–2027 (Usd Billion)
Table 50 Active Pharmaceutical Ingredients Market, By Region, 2022–2027 (Usd Billion)
Table 51 North America: Active Pharmaceutical Ingredients Market, By Country, 2022–2027 (Usd Billion)
Table 52 North America: Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 53 North America: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 54 North America: Synthetic Active Pharmaceutical Ingredients Market, Bytype, 2022–2027 (Usd Billion)
Table 55 North America: Biotech Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 56 North America: Biotech Active Pharmaceutical Ingredients Market, Byproduct, 2022–2027 (Usd Billion)
Table 57 North America: Active Pharmaceutical Ingredients Market, By Type Of Drug,2022–2027 (Usd Billion)
Table 58 North America: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usd Billion)
Table 59 North America: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 60 Indicative List Of Recent Fda Approvals For Drug Delivery Products
Table 61 Us: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 62 Us: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 63 Us: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 64 Us: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 65 Us: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 66 Us: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 67 Us: Active Pharmaceutical Ingredients Market, By Therapeutic Application,2022–2027 (Usd Billion)
Table 68 Canada: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 69 Canada: Active Pharmaceutical Ingredients Market, By Type Of Synthesis,2022–2027 (Usd Billion)
Table 70 Canada: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 71 Canada: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 72 Canada: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 73 Canada: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027(Usd Billion)
Table 74 Canada: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 75 Europe: Active Pharmaceutical Ingredients Market, By Country, 2022–2027(Usd Billion)
Table 76 Europe: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 77 Europe: Active Pharmaceutical Ingredients Market, By Type Of Synthesis,2022–2027 (Usd Billion)
Table 78 Europe: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 79 Europe: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 80 Europe: Biotech Active Pharmaceutical Ingredients Market, By Product,2022–2027 (Usd Billion)
Table 81 Europe: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 82 Europe: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027(Usd Billion)
Table 83 Europe: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 84 Germany: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 85 Germany: Active Pharmaceutical Ingredients Market, By Type Of Synthesis,2022–2027 (Usd Billion)
Table 86 Germany: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 87 Germany: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 88 Germany: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 89 Germany: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027(Usd Billion)
Table 90 Germany: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 91 France: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 92 France: Active Pharmaceutical Ingredients Market, By Type Of Synthesis,2022–2027 (Usd Billion)
Table 93 France: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 94 France: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 95 France: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 96 France: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027(Usd Billion)
Table 97 France: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 98 Uk: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 99 Uk: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 100 Uk: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 101 Uk: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 102 Uk: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 103 Uk: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 104 Uk: Active Pharmaceutical Ingredients Market, By Therapeutic Application,2022–2027 (Usd Billion)
Table 105 Italy: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 106 Italy: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 107 Italy: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 108 Italy: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 109 Italy: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 110 Italy: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 111 Italy: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 112 Spain: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 113 Spain: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 114 Spain: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 115 Spain: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Million)
Table 116 Spain: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 117 Spain: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdmillion)
Table 118 Spain: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Million)
Table 119 Rest Of Europe: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 120 Rest Of Europe: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 121 Rest Of Europe: Synthetic Active Pharmaceutical Ingredients Market, Bytype, 2022–2027 (Usd Billion)
Table 122 Rest Of Europe: Biotech Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 123 Rest Of Europe: Active Pharmaceutical Ingredients Market, By Type Ofdrug, 2022–2027 (Usd Billion)
Table 124 Rest Of Europe: Active Pharmaceutical Ingredients Market, By Potency,2022–2027 (Usd Billion)
Table 125 Rest Of Europe: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 126 Asia Pacific: Active Pharmaceutical Ingredients Market, By Country, 2022–2027 (Usd Billion)
Table 127 Asia Pacific: Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 128 Asia Pacific: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 129 Asia Pacific: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 130 Asia Pacific: Biotech Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 131 Asia Pacific: Biotech Active Pharmaceutical Ingredients Market, Byproduct, 2022–2027 (Usd Million)
Table 132 Asia Pacific: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 133 Asia Pacific: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usd Billion)
Table 134 Asia Pacific: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 135 Japan: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 136 Japan: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 137 Japan: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 138 Japan: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 139 Japan: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027 (Usd Billion)
Table 140 Japan: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 141 Japan: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 142 China: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 143 China: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 144 China: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 145 China: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 146 China: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 147 China: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 148 China: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 149 India: Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usdbillion)
Table 150 India: Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022–2027 (Usd Billion)
Table 151 India: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 152 India: Biotech Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 153 India: Active Pharmaceutical Ingredients Market, By Type Of Drug, 2022–2027(Usd Billion)
Table 154 India: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usdbillion)
Table 155 India: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 156 South Korea: Active Pharmaceutical Ingredients Market, By Type, 2022–2027(Usd Billion)
Table 157 South Korea: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 158 South Korea: Synthetic Active Pharmaceutical Ingredients Market, By Type, 2022–2027 (Usd Billion)
Table 159 South Korea: Biotech Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 160 South Korea: Active Pharmaceutical Ingredients Market, By Type Of Drug,2022–2027 (Usd Billion)
Table 161 South Korea: Active Pharmaceutical Ingredients Market, By Potency, 2022–2027 (Usd Billion)
Table 162 South Korea: Active Pharmaceutical Ingredients Market, By Therapeuticapplication, 2022–2027 (Usd Billion)
Table 163 Rest Of Asia Pacific: Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 164 Rest Of Asia Pacific: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 165 Rest Of Asia Pacific: Synthetic Active Pharmaceutical Ingredients Market,By Type, 2022–2027 (Usd Billion)
Table 166 Rest Of Asia Pacific: Biotech Active Pharmaceutical Ingredients Market, Bytype, 2022–2027 (Usd Billion)
Table 167 Rest Of Asia Pacific: Active Pharmaceutical Ingredients Market, By Type Ofdrug, 2022–2027 (Usd Billion)
Table 168 Rest Of Asia Pacific: Active Pharmaceutical Ingredients Market, By Potency,2022–2027 (Usd Billion)
Table 169 Rest Of Asia Pacific: Active Pharmaceutical Ingredients Market, Bytherapeutic Application, 2022–2027 (Usd Billion)
Table 170 Rest Of The World: Active Pharmaceutical Ingredients Market, By Type,2022–2027 (Usd Billion)
Table 171 Rest Of The World: Active Pharmaceutical Ingredients Market, By Type Ofsynthesis, 2022–2027 (Usd Billion)
Table 172 Rest Of The World: Synthetic Active Pharmaceutical Ingredients Market, Bytype, 2022–2027 (Usd Billion)
Table 173 Rest Of The World: Biotech Active Pharmaceutical Ingredients Market, Bytype, 2022–2027 (Usd Billion)
Table 174 Rest Of The World: Active Pharmaceutical Ingredients Market, By Type Ofdrug, 2022–2027 (Usd Billion)
Table 175 Rest Of The World: Active Pharmaceutical Ingredients Market, By Potency,2022–2027 (Usd Billion)
Table 176 Rest Of The World: Active Pharmaceutical Ingredients Market, Bytherapeutic Application, 2022–2027 (Usd Billion)
Table 177 Active Pharmaceutical Ingredients Market Player Ranking, 2018
Table 178 Product Launches, 2019–2021
Table 179 Expansions, 2019–2021
Table 180 Acquisitions, 2019–2021

List Of Figures

Figure 1 Active Pharmaceutical Ingredients Market: Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown Of Primary Interviews
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Active Pharmaceutical Ingredients Market, By Type, 2022 Vs. 2027 (Usd Billion)
Figure 8 Active Pharmaceutical Ingredients Market, By Type Of Synthesis, 2022 Vs.

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs